Diabeloop in the news
Automated insulin delivery system
Tamtam found 20 recent articles about Diabeloop.
- Diabeloop et Glooko : le système DBLG1 s’ouvre à la télésurveillance via Glooko XT® en France
Diabeloop's DBLG1 automated insulin delivery system now integrates with Glooko XT® for remote diabetes monitoring in France, improving patient follow-up and clinical analysis.
- ViCentra Kaleido with G7, DBLG2 is now available, Diabeloop says
Diabeloop announces its DBLG2 automated insulin delivery algorithm is now compatible with Dexcom G7 and ViCentra Kaleido, launching in Germany and soon in the Netherlands.
- Diabeloop Unveils New DBLG2 Demo App: Experience the Future of Automated Insulin Delivery Simulation
Diabeloop launched a new interactive DBLG2 Demo App on the Google Play Store in Germany and the Netherlands to simulate its automated insulin delivery system for diabetes management.
- ViCentra Announces Commercial Launch of New
ViCentra is launching a smartphone-controlled insulin pump system in Germany and the Netherlands that integrates Diabeloop's DBLG2 algorithm and Dexcom G7 sensors.
- Diabeloop Announces CE Marking and Gradual Launch of the New DBLG2 System, Integrated with Dexcom G7 CGM and ViCentra’s Kaleido Insulin Delivery System
Diabeloop is launching the DBLG2 automated insulin delivery system in Europe, featuring a smartphone app integrated with Dexcom G7 sensors and Kaleido pumps.
- Diabeloop’s DBLG2 receives FDA and CE clearance for automated insulin delivery without meal input
DBLG2 has secured FDA and CE clearance for an AI-driven insulin system that manages type 1 diabetes without requiring users to manualy log meals.
- Sequel, Diabeloop Team Up on twiist Insulin Delivery System
Diabeloop and Sequel Med Tech are collaborating to launch the twiist AID system with an integrated insulin-dosing algorithm in the United States.
- Diabeloop ouvre le marché américain de l’insuline automatisée
FDA clearance for the DBLG2 algorithm allows entry into the U.S. market for automated insulin delivery starting in 2026.
- Diabeloop’s DBLG2 and a Closed Loop With the Twiist Delivery System for T1D
Diabeloop received FDA clearance for its DBLG2 algorithm and partnered with Sequel Med Tech to launch a fully automated, hands-off insulin delivery system by 2027.
- Grenoble. Les portes du marché américain s’ouvrent pour Diabeloop
Diabeloop secured FDA clearance for its AI-driven automated insulin delivery algorithm, enabling the company to enter the United States market.
- Diabeloop obtient l’accord de la FDA pour son algorithme de gestion de l’insuline
Diabeloop received FDA approval for its type 1 diabetes insulin management algorithm.
- Sequel Med Tech, Diabeloop to integrate automated insulin delivery algorithm into twiist pump
Sequel Med Tech is integrating Diabeloop's DBLG2 algorithm into its twiist insulin pump to create a more precise, automated delivery system for U.S. patients.
- Sequel Med Tech, Diabeloop to integrate automated insulin delivery algorithm into twiist pump
Sequel Med Tech and Diabeloop are partnering to launch the first U.S. commercial insulin pump integrated with the DBLG2 automated algorithm by 2027.
- Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App
Diabeloop secured FDA clearance for its DBLG2 automated insulin delivery app, facilitating its entry into the U.S. market and expansion of its interoperable device partnerships.
- Diabeloop wins FDA nod for new automated insulin delivery algorithm
Diabeloop secured FDA clearance for its DBLG2 automated insulin delivery algorithm, enabling partnerships with various hardware manufacturers for diabetes management.
- Pourquoi Diabeloop engage-t-elle une procédure de sauvegarde ?
Diabeloop, a medtech company focused on diabetes treatment, is initiating safeguard proceedings to reorganize and protect itself from creditors.
- Diabeloop en sauvegarde : une étape clé pour l'innovation médicale
Diabeloop is undergoing a court-protected restructuring to renegotiate debt while expanding international partnerships for its automated insulin delivery technology.
- Pourquoi l'entreprise iséroise Diabeloop est en procédure de sauvegarde
Diabeloop has entered a court-monitored safeguard procedure to restructure heavy debt while continuing its international expansion in automated insulin delivery.
- Etude sur l’efficacité et la sécurité du système de boucle fermée hybride Diabeloop chez les enfants en pré-puberté souffrant de diabète de type 1
Clinical study on the effectiveness of an automated insulin delivery system for pre-pubertal children with type 1 diabetes.
- Diabeloop’s Automated Insulin Delivery System to Launch In Europe
Diabeloop has received European approval for its DBLG1 automated insulin delivery system, featuring a hybrid closed-loop algorithm that improves blood sugar control.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Diabeloop?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies